Intellia Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Intellia Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
  • Intellia Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 790 %, a 16.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 790 -161 -16.9% Sep 30, 2024
Q2 2024 861 -1.9 -0.22% Jun 30, 2024
Q1 2024 918 +106 +13.1% Mar 31, 2024
Q4 2023 925 +167 +22% Dec 31, 2023
Q3 2023 952 +281 +41.9% Sep 30, 2023
Q2 2023 863 +154 +21.8% Jun 30, 2023
Q1 2023 812 +101 +14.2% Mar 31, 2023
Q4 2022 758 -5.85 -0.77% Dec 31, 2022
Q3 2022 671 -200 -23% Sep 30, 2022
Q2 2022 709 -148 -17.3% Jun 30, 2022
Q1 2022 711 -156 -18% Mar 31, 2022
Q4 2021 764 -51.4 -6.3% Dec 31, 2021
Q3 2021 871 +106 +13.9% Sep 30, 2021
Q2 2021 857 +80.3 +10.3% Jun 30, 2021
Q1 2021 867 +75.8 +9.58% Mar 31, 2021
Q4 2020 815 +22.1 +2.78% Dec 31, 2020
Q3 2020 765 -26 -3.29% Sep 30, 2020
Q2 2020 777 -79.7 -9.31% Jun 30, 2020
Q1 2020 791 -160 -16.8% Mar 31, 2020
Q4 2019 793 -298 -27.3% Dec 31, 2019
Q3 2019 791 -421 -34.8% Sep 30, 2019
Q2 2019 856 -292 -25.4% Jun 30, 2019
Q1 2019 951 -119 -11.1% Mar 31, 2019
Q4 2018 1.09K +85 +8.44% Dec 31, 2018
Q3 2018 1.21K +268 +28.4% Sep 30, 2018
Q2 2018 1.15K +116 +11.2% Jun 30, 2018
Q1 2018 1.07K -69.1 -6.07% Mar 31, 2018
Q4 2017 1.01K -91 -8.3% Dec 31, 2017
Q3 2017 944 -178 -15.9% Sep 30, 2017
Q2 2017 1.03K Jun 30, 2017
Q1 2017 1.14K Mar 31, 2017
Q4 2016 1.1K Dec 31, 2016
Q3 2016 1.12K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.